ZA933508B - Self-sticking matrix system for the sustained transcutneous release of piribedil - Google Patents

Self-sticking matrix system for the sustained transcutneous release of piribedil

Info

Publication number: ZA933508B
Authority: ZA; South Africa
Prior art keywords: piribedil; self; release; transcutneous; sustained
Prior art date: 1992-05-19

Application number

ZA933508A

Other languages

English (en)

Inventor

Alain Cuine

Isabelle Rault

Francoise Arnaud

Olivier Crambes

Gerald Pichon

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-19

Filing date

1993-05-19

Publication date

1993-12-10

1993-05-19 Application filed by Adir filed Critical Adir

1993-12-10 Publication of ZA933508B publication Critical patent/ZA933508B/xx

Links

OQDPVLVUJFGPGQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine Chemical compound C=1C=C2OCOC2=CC=1CN(CC1)CCN1C1=NC=CC=N1 OQDPVLVUJFGPGQ-UHFFFAOYSA-N 0.000 title abstract 3
229960004310 piribedil Drugs 0.000 title abstract 3
239000011159 matrix material Substances 0.000 title abstract 2
230000002459 sustained effect Effects 0.000 title 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
239000005977 Ethylene Substances 0.000 abstract 1
239000000853 adhesive Substances 0.000 abstract 1
229920001577 copolymer Polymers 0.000 abstract 1
238000009792 diffusion process Methods 0.000 abstract 1
238000013265 extended release Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Materials For Medical Uses (AREA)
Absorbent Articles And Supports Therefor (AREA)
Plural Heterocyclic Compounds (AREA)

ZA933508A 1992-05-19 1993-05-19 Self-sticking matrix system for the sustained transcutneous release of piribedil ZA933508B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9206037A FR2691361B1 (fr)	1992-05-19	1992-05-19	Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.

Publications (1)

Publication Number	Publication Date
ZA933508B true ZA933508B (en)	1993-12-10

Family

ID=9429912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA933508A ZA933508B (en)	1992-05-19	1993-05-19	Self-sticking matrix system for the sustained transcutneous release of piribedil

Country Status (11)

Country	Link
EP (1)	EP0571264B1 (da)
JP (1)	JPH0632738A (da)
AT (1)	ATE173623T1 (da)
AU (1)	AU656266B2 (da)
CA (1)	CA2096511A1 (da)
DE (1)	DE69322201T2 (da)
DK (1)	DK0571264T3 (da)
ES (1)	ES2127259T3 (da)
FR (1)	FR2691361B1 (da)
NZ (1)	NZ247648A (da)
ZA (1)	ZA933508B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2675383B1 (fr) *	1991-04-18	1995-05-12	Bernard Aranda	Utilisation d'un medicament pour la fabrication d'un medicament destine au traitement des vessies hyperactives ou instables.
US5840327A (en) *	1995-08-21	1998-11-24	Alza Corporation	Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (fr) *	1996-01-31	1998-03-20	Atohaas Holding Cv	Composition adhesive pour materiaux en (co) polymere (meth) acrylique
CN103373991A (zh) *	2013-07-12	2013-10-30	安徽安腾药业有限责任公司	高纯度、高收率制备吡贝地尔的方法
CN118743684B (zh) *	2024-06-18	2025-08-26	石家庄四药有限公司	一种吡贝地尔缓释片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2355502A1 (fr) *	1976-06-23	1978-01-20	Roussel Uclaf	Application a titre de medicaments d'un derive de la piperazine et de ses sels
DE68917292T2 (de) *	1988-02-26	1995-02-02	Riker Laboratories Inc	Transdermales estradiol als therapeutisches sytem.
FR2664815B1 (fr)	1990-07-23	1994-11-04	Adir	Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
GB9102089D0 (en) *	1991-01-31	1991-03-13	Johnson & Johnson Medical	Net wound dressings

1992
- 1992-05-19 FR FR9206037A patent/FR2691361B1/fr not_active Expired - Fee Related
1993
- 1993-05-17 JP JP5115044A patent/JPH0632738A/ja active Pending
- 1993-05-18 CA CA002096511A patent/CA2096511A1/fr not_active Abandoned
- 1993-05-18 AT AT93401262T patent/ATE173623T1/de not_active IP Right Cessation
- 1993-05-18 ES ES93401262T patent/ES2127259T3/es not_active Expired - Lifetime
- 1993-05-18 DE DE69322201T patent/DE69322201T2/de not_active Expired - Fee Related
- 1993-05-18 EP EP93401262A patent/EP0571264B1/fr not_active Expired - Lifetime
- 1993-05-18 DK DK93401262T patent/DK0571264T3/da active
- 1993-05-18 AU AU38607/93A patent/AU656266B2/en not_active Ceased
- 1993-05-19 NZ NZ247648A patent/NZ247648A/xx unknown
- 1993-05-19 ZA ZA933508A patent/ZA933508B/xx unknown

Also Published As

Publication number	Publication date
EP0571264A1 (fr)	1993-11-24
FR2691361B1 (fr)	1994-07-08
AU3860793A (en)	1993-11-25
EP0571264B1 (fr)	1998-11-25
DK0571264T3 (da)	1999-08-09
ES2127259T3 (es)	1999-04-16
FR2691361A1 (fr)	1993-11-26
AU656266B2 (en)	1995-01-27
DE69322201D1 (de)	1999-01-07
ATE173623T1 (de)	1998-12-15
NZ247648A (en)	1995-01-27
CA2096511A1 (fr)	1993-11-20
DE69322201T2 (de)	1999-06-24
JPH0632738A (ja)	1994-02-08

Publication	Publication Date	Title
EP0168044A3 (en)	1987-04-15	Sustained release tablet
AU6569694A (en)	1994-11-08	Active substance-containing plaster
AU1835492A (en)	1992-12-24	Carrier catalyst, process for its preparation, and its use for the preparation of vinyl acetate
EP0643976A3 (en)	1995-05-31	Cardioplegia administration device.
AU6383996A (en)	1997-01-09	Multiple-channel, total-reflection optic with controllable d ivergence
AU7211287A (en)	1987-11-05	Controlled release drug delivery system for the peridontal pocket
EP0656771A4 (en)	1996-07-31	DEVICE FOR TRANSDERMAL DRUG DELIVERY.
DE68908215D1 (de)	1993-09-16	Einrichtungen und systeme, basierend auf supraleitenden materialien.
EP0606790A3 (en)	1995-09-20	Doll or activated figure delivering a message of selected words, sentences or subjects.
AU4501393A (en)	1994-01-24	Curving device, especially for seat backs
TW349185B (en)	1999-01-01	A semiconductor device
FI891252A7 (fi)	1989-09-19	1,3,4,5-tetrahydrobenz /c,d/ indol.
ZA963642B (en)	1997-11-10	Catalyst for vinyl acetate manufacture.
CY2333B1 (en)	2004-02-06	10-Aminoaliphatyl-dibenz (b,f) oxepins with antineur odegenarative activity.
HU9501597D0 (en)	1995-08-28	Insecticidal 5-substituted-2,4-diaminopyrimidine derivatives
NZ247648A (en)	1995-01-27	Self-sticking matrix system for the sustained release of piribedil
AU8121391A (en)	1992-01-30	Self-sticking matrix system for the sustained transcutaneous release of piribedil
EG18865A (en)	1994-07-30	Phenoxypenythioureas, phenoxyphenylisothiourreas and phenoxyphenylcarbodiimides and use thereof for controlling pests.
PH31213A (en)	1998-05-05	Drug for neuroprotection.
EP0602414A3 (en)	1995-02-22	Mail flow compensation device.
EP0461913A3 (en)	1991-12-27	Process for the catalytic cyclization of alkenylbenzenes.
FR2693965B1 (fr)	1994-09-23	Dispositif pneumatique de retenue en côte.
NO943436D0 (no)	1994-09-15	Betjeningsinnretning for en setebærer for stoler, særlig svingstoler
FI890266L (fi)	1989-07-20	Foerfarande foer framstaellning av affino-enzymatiska foereningar, vilka anvaends foer visuell bestaemning av kolesterol pao hudytan.
ES2154392T3 (es)	2001-04-01	Composiciones adhesivas termofusibles a base de copolimeros que comprenden etileno, acetato de vinilo y vinilalcoxisilano.